Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 209

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 209
---
 Pre -FundedWarrants outstanding. Class D Common Stock Warrants In connection with the February 2024 Public Offering, the Company issued and has outstanding 2,730,000 warrants shares of common stock to purchase up to 170,628shares of common stock at an exercise price of $72.48 per share, valued on the public offering purchase date in the aggregate at $6.3 million and included in the issuance costs of the public offering and treated as equity. The warrants were exercisable immediately upon issuance, provide for a cash or cashless exercise right and expire on February 5, 2029. As of December 31, 2024, the Company issued 6,312shares of common stock in connection with a notice of cash exercise for the Class D Common Stock Warrants issued in connection with the February 2024 Public Offering with a total purchase price of $241,390. As of December 31, 2024, the Company issued 159,249shares of common stock in connection with notices of cash exercise for the Class D Common Stock Existing Warrants issued in connection with the Class D Warrant Inducement with a total purchase price of $3.8 million. As part of the Class D Warrant Inducement the Class D Common Stock Warrants the Company issued common stock to a third party consultant on June 11, 2024, as a result the exercise price of the Class D Common Stock Warrants were reset from $72.48 to $38.24. Additionally, on August 22, 2024, the exercise price of the Class D Common Stock Warrants was reset from $38.24 to $16.00. As part of the 2025 Reverse Stock Split on January 28, 2025, the exercise price of the Class D Common Stock Warrants was reset from $16.00 to $3.849. As of December 31, 2024 there were 80,940 Class D Common Stock Warrants outstanding to purchase up to 5,060shares of common stock that were not included in the Class D Warrant Inducement. F-23

REVELATION BIOSCIENCES, INC. Notes to the Consolidated Financial Statements 10. Warrants (cont.) The fair value of the Class D Common Stock Warrants were originally estimated using the Black -Scholesoption pricing model with the following assumptions:

| Volatility              |     |  100 | % |
| Expected term (years)